• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放疗增强了抗 PD-1 治疗胃癌的疗效。

Radiation therapy enhanced therapeutic efficacy of anti-PD1 against gastric cancer.

机构信息

Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun 130021, P.R. China.

Department of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun 130033, P.R. China.

出版信息

J Radiat Res. 2020 Nov 16;61(6):851-859. doi: 10.1093/jrr/rraa077.

DOI:10.1093/jrr/rraa077
PMID:32960261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7674687/
Abstract

Radiation therapy is an important method in tumor treatment with distinct responses. This study aimed to investigate the immune effects of radiation therapy on the syngeneic gastric tumor model. Mouse forestomach carcinoma (MFC) cells were irradiated with different X-ray doses. Cell proliferation was determined by clonogenic assay. Gene and protein expression were determined by real-time quantitative PCR and western blot, respectively. The tumor model was established by subcutaneously injecting tumor cells in 615-(H-2 K) mice. Levels of immune-related factors in tumor tissues were determined by immunohistochemistry and flow cytometry. 5 Gy × 3 (three subfractions with 4 h interval) treatment significantly inhibited cell proliferation. Protein expression of stimulator of interferon genes (Sting) and gene expression of IFNB1, TNFα as well as CXCL-9 significantly increased in MFC cells after irradiation. In the MFC mouse model, no obvious tumor regression was observed after irradiation treatment. Further studies showed Sting protein expression, infiltration of dendritic cells and T cells, and significantly increased PD-1/PD-L1 expression in tumor tissues. Moreover, the irradiation treatment activated T cells and enhanced the therapeutic effects of anti-PD1 antibody against MFC tumor. Our data demonstrated that although the MFC tumor was not sensitive to radiation therapy, the tumor microenvironment could be primed after irradiation. Radiation therapy combined with immunotherapy can greatly improve anti-tumor activities in radiation therapy-insensitive tumor models.

摘要

放射治疗是肿瘤治疗的一种重要方法,具有明显的疗效。本研究旨在探讨放射治疗对同源胃肿瘤模型的免疫效应。用不同剂量 X 射线照射小鼠前胃癌细胞(MFC)。用集落形成实验测定细胞增殖。实时定量 PCR 和 Western blot 分别测定基因和蛋白表达。通过将肿瘤细胞皮下注射到 615-(H-2 K)小鼠中建立肿瘤模型。用免疫组化和流式细胞术测定肿瘤组织中免疫相关因子的水平。5 Gy×3(3 次分割,间隔 4 h)治疗明显抑制细胞增殖。照射后 MFC 细胞中干扰素基因刺激物(Sting)蛋白表达和 IFNB1、TNFα 以及 CXCL-9 基因表达显著增加。在 MFC 小鼠模型中,照射治疗后未见明显肿瘤消退。进一步的研究表明,Sting 蛋白表达、树突状细胞和 T 细胞浸润以及肿瘤组织中 PD-1/PD-L1 表达显著增加。此外,照射治疗激活了 T 细胞,并增强了抗 PD-1 抗体对 MFC 肿瘤的治疗效果。我们的数据表明,尽管 MFC 肿瘤对放射治疗不敏感,但照射后肿瘤微环境可以被激活。放射治疗联合免疫治疗可以大大提高放射治疗不敏感肿瘤模型的抗肿瘤活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/307390641ebc/rraa077f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/70f1c348f3d9/rraa077f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/6e5d0c866e8c/rraa077f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/20bbc475e024/rraa077f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/1463e16ecde8/rraa077f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/307390641ebc/rraa077f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/70f1c348f3d9/rraa077f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/6e5d0c866e8c/rraa077f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/20bbc475e024/rraa077f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/1463e16ecde8/rraa077f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2736/7674687/307390641ebc/rraa077f5.jpg

相似文献

1
Radiation therapy enhanced therapeutic efficacy of anti-PD1 against gastric cancer.放疗增强了抗 PD-1 治疗胃癌的疗效。
J Radiat Res. 2020 Nov 16;61(6):851-859. doi: 10.1093/jrr/rraa077.
2
Efficacy of anti-programmed cell death protein 1 monoclonal antibody combined with bevacizumab and/or Pseudomonas aeruginosa injection in transplanted tumor of mouse forestomach carcinoma cell gastric cancer in mice and its mechanism in regulating tumor immune microenvironment.抗程序性细胞死亡蛋白 1 单克隆抗体联合贝伐珠单抗和/或铜绿假单胞菌注射液对小鼠胃癌移植瘤的疗效及其对肿瘤免疫微环境的调控机制。
Clin Exp Immunol. 2023 Oct 13;213(3):328-338. doi: 10.1093/cei/uxad069.
3
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.ILT4 抑制可预防 TAM 和功能失调 T 细胞介导的免疫抑制,并增强 EGFR 激活的 NSCLC 中抗 PD-L1 治疗的疗效。
Theranostics. 2021 Jan 19;11(7):3392-3416. doi: 10.7150/thno.52435. eCollection 2021.
4
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.抗 PD-1 治疗后转移性胃癌放疗增敏。
Gastric Cancer. 2020 Sep;23(5):893-903. doi: 10.1007/s10120-020-01058-4. Epub 2020 Mar 16.
5
[Effect of cisplatin alone or combined with monoclonal anti-programmed death ligand-1 antibody on lung adenocarcinoma cell line SPCA-1 and T lymphocytes].顺铂单独或联合单克隆抗程序性死亡配体-1抗体对肺腺癌细胞系SPCA-1和T淋巴细胞的作用
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jun;37(6):416-20.
6
(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ.(3R)-5,6,7-三羟基-3-异丙基-3-甲基异黄烷-1-酮通过抑制 PI3Kδ/γ 增强了抗 PD1 抗体的治疗效果。
Immunopharmacol Immunotoxicol. 2019 Dec;41(6):599-606. doi: 10.1080/08923973.2019.1678634. Epub 2019 Nov 6.
7
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.SIRT7 缺失通过 MEF2D 调控程序性细胞死亡配体 1 增加肝癌细胞中检查点抑制剂的疗效。
Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31.
8
Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade.三种 CpG 寡脱氧核苷酸类药物在单药治疗和联合 PD-1 阻断治疗中的抗肿瘤疗效差异。
Pharmacol Res. 2020 Nov;161:105293. doi: 10.1016/j.phrs.2020.105293. Epub 2020 Nov 8.
9
(-)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) Quinic Acid Inhibits the Function of Myeloid-Derived Suppressor Cells to Enhance the Efficacy of Anti-PD1 against Colon Cancer.(-)-4-O-(4-O-β-D-葡萄糖基咖啡酰奎宁酸抑制髓源抑制细胞的功能,增强抗 PD-1 治疗结肠癌的疗效。
Pharm Res. 2018 Jul 30;35(9):183. doi: 10.1007/s11095-018-2459-5.
10
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.非同质肿瘤内放射剂量与 PD1 和 CXCR2 阻断协同作用。
Nat Commun. 2024 Oct 14;15(1):8845. doi: 10.1038/s41467-024-53015-9.

引用本文的文献

1
Association between adjuvant radiotherapy in adults with gastric cancer and risk of second primary malignancy: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.成人胃癌辅助放疗与第二原发性恶性肿瘤风险之间的关联:一项使用监测、流行病学和最终结果数据库的回顾性队列研究。
BMJ Open. 2025 Feb 12;15(2):e086349. doi: 10.1136/bmjopen-2024-086349.
2
Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer.程序性死亡受体-1/程序性死亡配体1抑制剂:胃癌的临床进展与生物标志物探索
Heliyon. 2024 Oct 4;10(20):e38710. doi: 10.1016/j.heliyon.2024.e38710. eCollection 2024 Oct 30.
3

本文引用的文献

1
Combining radiotherapy with immunotherapy: the past, the present and the future.放射治疗与免疫治疗的联合应用:过去、现在与未来。
Br J Radiol. 2017 Aug;90(1076):20170157. doi: 10.1259/bjr.20170157. Epub 2017 May 25.
2
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.调节PD-L1和PD-L2表达的干扰素受体信号通路
Cell Rep. 2017 May 9;19(6):1189-1201. doi: 10.1016/j.celrep.2017.04.031.
3
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.抗claudin 18.2抗体作为晚期胃癌的新型靶向治疗方法。
The cGAS/STING Pathway-A New Potential Biotherapeutic Target for Gastric Cancer?
cGAS/STING通路——胃癌的一个新的潜在生物治疗靶点?
J Pers Med. 2024 Jul 9;14(7):736. doi: 10.3390/jpm14070736.
4
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors.超越成功:揭示实体肿瘤中放射治疗和免疫治疗的隐藏潜力。
Cancer Commun (Lond). 2024 Jul;44(7):739-760. doi: 10.1002/cac2.12576. Epub 2024 Jun 5.
5
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity.放疗重塑肿瘤微环境以增强免疫治疗敏感性。
Cell Death Dis. 2023 Oct 13;14(10):679. doi: 10.1038/s41419-023-06211-2.
6
CD45 erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells.CD45 红细胞祖细胞通过诱导淋巴管内皮细胞的混合上皮/间充质状态促进胃癌淋巴结转移。
Gastric Cancer. 2023 Nov;26(6):918-933. doi: 10.1007/s10120-023-01425-x. Epub 2023 Sep 7.
7
Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research.免疫治疗与放射治疗联合应用于胃肠道肿瘤:对当前文献和正在进行的研究的评价。
Curr Oncol. 2023 Jul 5;30(7):6432-6446. doi: 10.3390/curroncol30070473.
8
Efficacy of anti-programmed cell death protein 1 monoclonal antibody combined with bevacizumab and/or Pseudomonas aeruginosa injection in transplanted tumor of mouse forestomach carcinoma cell gastric cancer in mice and its mechanism in regulating tumor immune microenvironment.抗程序性细胞死亡蛋白 1 单克隆抗体联合贝伐珠单抗和/或铜绿假单胞菌注射液对小鼠胃癌移植瘤的疗效及其对肿瘤免疫微环境的调控机制。
Clin Exp Immunol. 2023 Oct 13;213(3):328-338. doi: 10.1093/cei/uxad069.
9
Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group.老年寡转移患者的立体定向体部放疗与免疫治疗:国际老年放射治疗组提出的范例
Cancers (Basel). 2022 Dec 30;15(1):244. doi: 10.3390/cancers15010244.
10
Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer.放射性核素标记的双碘苯丁酸二乙酰胺单克隆抗体联合胞嘧啶脱氨酶基因治疗对膀胱癌裸鼠模型抑瘤作用的增强及其放射敏感性调控
J Radiat Res. 2023 Jan 20;64(1):85-90. doi: 10.1093/jrr/rrac075.
J Hematol Oncol. 2017 May 12;10(1):105. doi: 10.1186/s13045-017-0473-4.
4
Radiotherapy and immunotherapy: a beneficial liaison?放疗与免疫治疗:有益的联合?
Nat Rev Clin Oncol. 2017 Jun;14(6):365-379. doi: 10.1038/nrclinonc.2016.211. Epub 2017 Jan 17.
5
Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.将放射治疗与免疫治疗相结合用于癌症治疗的基本原理和证据。
Cancer Immunol Immunother. 2017 Mar;66(3):281-298. doi: 10.1007/s00262-016-1914-6. Epub 2016 Oct 14.
6
The host STING pathway at the interface of cancer and immunity.癌症与免疫界面处的宿主STING通路。
J Clin Invest. 2016 Jul 1;126(7):2404-11. doi: 10.1172/JCI86892.
7
Systemic Immunotherapy for the Treatment of Brain Metastases.用于治疗脑转移瘤的全身免疫疗法。
Front Oncol. 2016 Mar 9;6:49. doi: 10.3389/fonc.2016.00049. eCollection 2016.
8
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
9
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.依赖于STING的胞质DNA传感促进免疫原性肿瘤中辐射诱导的I型干扰素依赖性抗肿瘤免疫。
Immunity. 2014 Nov 20;41(5):843-52. doi: 10.1016/j.immuni.2014.10.019. Epub 2014 Nov 6.
10
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.依赖于干扰素基因刺激蛋白(STING)的胞质DNA传感介导免疫原性肿瘤的固有免疫识别。
Immunity. 2014 Nov 20;41(5):830-42. doi: 10.1016/j.immuni.2014.10.017. Epub 2014 Nov 5.